Related Experiment Video
Updated: Feb 19, 2026
05:13
LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Published on: January 24, 2025
845
Bacterial keratitis: Photodynamic inactivation reduced experimental inflammation
Mona Deichelbohrer1, Ming-Feng Wu2, Berthold Seitz2
1Institute of Anatomy and Cell Biology, Medical Faculty, Saarland University, D-66424 Homburg/Saar, Germany.
Experimental and Therapeutic Medicine
|November 7, 2017
Summary
Photodynamic inactivation (PDI) using chlorin e6 (Ce6) effectively reduced corneal inflammation and hypopyon severity in a mouse model of bacterial keratitis. This suggests PDI may offer a promising new treatment for severe bacterial keratitis.
Area of Science:
- Ophthalmology
- Microbiology
- Photomedicine
Background:
- Bacterial keratitis presents significant challenges in clinical treatment.
- Current therapeutic strategies for bacterial keratitis are limited.
Purpose of the Study:
- To develop a murine model for bacterial keratitis.
- To evaluate the efficacy of chlorin e6 (Ce6)-mediated photodynamic inactivation (PDI) in treating corneal inflammation.
Main Methods:
- A Pseudomonas aeruginosa keratitis model was established in mice.
- Ce6 paste was applied to infected corneas followed by light exposure.
- Corneal thickness and hypopyon severity were assessed via light microscopy.
Main Results:
- Photodynamic inactivation significantly reduced maximal corneal thickness compared to the untreated group (220±8 µm vs. 290±16 µm).
- The severity of hypopyon was notably decreased in the treated group.
Conclusions:
- Ce6-mediated photodynamic inactivation demonstrates potential as an effective treatment for bacterial keratitis.
- PDI offers a promising therapeutic avenue for severe bacterial keratitis cases.
